These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24993741)

  • 1. The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study.
    Dogan Z; Sarikaya M; Ergul B; Filik L
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):242-5. PubMed ID: 24993741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients.
    Bonfigli AR; Boemi M; Festa R; Bonazzi P; Brandoni G; Spazzafumo L; Olivieri F; Ceriello A; Genovese S; Testa R
    Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):893-8. PubMed ID: 27480449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
    Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
    Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
    Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
    BMC Gastroenterol; 2016 Oct; 16(1):119. PubMed ID: 27716077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
    J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
    Sheu BS; Huang JJ; Yang HB; Huang AH; Wu JJ
    Aliment Pharmacol Ther; 2003 May; 17(10):1283-90. PubMed ID: 12755841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
    Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ
    J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation.
    Gen R; Demir M; Ataseven H
    South Med J; 2010 Mar; 103(3):190-6. PubMed ID: 20134372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
    Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Helicobacter pylori infection associated with glycemic control in diabetics?
    Dai YN; Yu WL; Zhu HT; Ding JX; Yu CH; Li YM
    World J Gastroenterol; 2015 May; 21(17):5407-16. PubMed ID: 25954115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
    Kutluk G; Tutar E; Bayrak A; Volkan B; Akyon Y; Celikel C; Ertem D
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1202-8. PubMed ID: 25171023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.
    Bago J; Galović A; Belosić Halle Z; Bilić A; Bevanda M; Bago P
    Wien Klin Wochenschr; 2004 Jul; 116(14):495-9. PubMed ID: 15379146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
    Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
    Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients.
    Demir M; Gokturk HS; Ozturk NA; Arslan H; Serin E; Yilmaz U
    South Med J; 2009 Nov; 102(11):1116-20. PubMed ID: 19864973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
    Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
    Greenberg ER; Anderson GL; Morgan DR; Torres J; Chey WD; Bravo LE; Dominguez RL; Ferreccio C; Herrero R; Lazcano-Ponce EC; Meza-Montenegro MM; Peña R; Peña EM; Salazar-Martínez E; Correa P; Martínez ME; Valdivieso M; Goodman GE; Crowley JJ; Baker LH
    Lancet; 2011 Aug; 378(9790):507-14. PubMed ID: 21777974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
    Prasertpetmanee S; Mahachai V; Vilaichone RK
    Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.